Abstract
The effects of fendiline on L-type Ca++ currents [ICa(L)] were investigated in rat ventricular cardiomyocytes using the patch-clamp technique both in the whole-cell disrupted-patch and in the cell-attached configuration. For comparison, the effects of verapamil were also investigated. Both compounds depressed the magnitude of whole cell ICa(L), verapamil being about 15 times more potent than fendiline. Verapamil did not change the time course of the current, whereas fendiline accelerated its decay when either Ca++ or Ba++ ions were used as charge carriers. In the presence of the Ca++agonist BayK8644 (10 μM), the potency ratio of fendiline/verapamil was inverted. BayK8644 (10 μM) also reversed the potency ratio of verapamil/fendiline in smooth muscle, with respect to changes in tension induced by K+ (48 mM). In single channel recordings at 0.1 Hz, in the presence of BayK8644 (1 μM) and using Ba++ ions as the charge carrier, fendiline (1 μM) reduced mean open time by 34% and channel availability by 8%; the ensemble average current of Ca++ channels was reduced by 43%. In the same experimental conditions, verapamil (1 μM) was ineffective. These results can be explained by the assumption that fendiline blocks Ca++ channels preferentially in the open state, in contrast to verapamil which blocks preferentially inactivated Ca++channels.
Footnotes
-
Send reprint requests to: Prof. Dr. H. Nawrath, Pharmakologisches Institut der Universität Mainz, Obere Zahlbacher Str. 67, D-55101 Mainz, Germany.
-
↵1 This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Umweltministerium of Rheinland-Pfalz (Germany), Thiemann Arzneimittel (Germany) (to H.N.) and the Otto Meyerhoff Center for Drug-Receptor Interactions at Bar-Ilan University (A.S.). This work contains parts of the M.D. thesis of G.K.
- Abbreviations:
- ICa(L)
- Ca++ current through L-type Ca++ channels
- IBa(L)
- Ba++ current through L-type Ca++channels
- Received August 14, 1997.
- Accepted January 23, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|